Navigation Links
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports
Date:9/2/2010

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins... -- DALLAS, Texas, September 2, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services, Surveys, Polls and Research Click to view news release full screen  

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports

 

DALLAS, Texas, September 2, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Manufacturing of Biologics (http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-i ncreasing-demand-for-monoclonal-ant/) - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Market Research Report in its store.

Browse the complete Report on: http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-in creasing-demand-for-monoclonal-ant/

Search More Then 45000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/)

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

GBI Research's report, "Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies", provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical ( http://www.reportsandreports.com/market-research/pharmaceuticals/) and biotech industry.

The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the manufacturing of biologics.

Scope The scope of this report includes: - Opportunities and challenges for manufacturers of biologics in the pharmaceuticals industry - Market revenues and forecasts for biologics manufacturing in the global pharmaceutical industry from 2009 to 2016. - The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China. - Processes involving the manufacturing of biologics including upstream and downstream bioprocessing. - Technology trends in upstream and downstream bioprocessing that shape the biomanufacturing industry and regulatory trends in the key markets. - Production capacities for the mammalian and microbial manufacturing facilities in the key regions. - Qualitative analysis of the market drivers, barriers, future outlook and challenges for the manufacturing of biologics in the pharmaceutical industry - Analysis of competitive landscape and the leading market players. Reasons to buy The report will enhance your decision making capability. It will allow you to: - Formulate strategies to increase your company's growth by understanding the new growth opportunities in the market for manufacturing of biologics - Work around the regulatory and technology hurdles by identifying the key trends shaping and driving the market for biomanufacturing. - Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the current competitive landscape and how it is evolving to meet the increasing demands - Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities. - Make more informed business decisions from the insightful and in-depth analysis of the market for biomanufacturing by analyzing the key technology trends that shape the growth of this market

Read Full TOC of Report : http://www.reportsandreports.com/market-reports/manufacturing-of-biologics-in creasing-demand-for-monoclonal-ant/

Browse all Pharmaceuticals Reports at http://www.reportsandreports.com/market-research/pharmaceuticals/ Browse All GBI Research Reports at http://www.reportsandreports.com/Publishers/gbi-research/

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

Contact: Ms. Sunita 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 http://www.reportsandreports.com/ http://reportsnreports.wordpress.com/ http://reportsandreports.blogspot.com/
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
3. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
4. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
5. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
6. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
7. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
8. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
9. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
10. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
11. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ORLANDO, Fla. , Feb. 8, 2016 ... and marketing high performance apparel for healthcare and other ... Bold Chief Executive Officer. He replaces Dale ... and remains Chairman. Mr. Bold is also joining Vestagen,s ... in a new class of active barrier technologies that ...
(Date:2/8/2016)... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ; ASX: UNS), ... announced that it will release its financial results for the ... close on February 9, 2016.  At this time, the Company ... results.    About Unilife Corporation --> ... Unilife Corporation UNIS / ASX: UNS) ...
(Date:2/8/2016)... Feb. 8, 2016  Astellas Pharma Inc. President and Chief ... of James Robinson as president, Americas Operations, for ... North and South America , effective April ... representing the commercial organization in the United States ... Masao Yoshida , who is retiring in June ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. ... organizations with the tools and information to lower the costs, and increase the ... cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... , MEDIA ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & ... nurses in the world with an estimated 5000 perioperative nurses in attendance ...
(Date:2/6/2016)... ... 2016 , ... With the FCPX LUT: Summer pack from Pixel ... A LUT is a Lookup Table that contains a mathematical formula for modifying an ... table. By manipulating each pixel, LUT's can change each color range differently, it gives ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Love is in ... in a variety of colors, assortments and packaging. This staple for Valentine’s Day is ... Kullen location. , For Valentine’s Day, not only are long-stem roses available, but ...
Breaking Medicine News(10 mins):